The study, led by the Hospital del Mar Research Institute and IRB Barcelona, shows that the determination of this protein, CTHRC1, can be used to assess patient prognosis. At the same time, it opens up new avenues to approach this type of tumour.

The research team has demonstrated that this biomarker can be detected using routine diagnostic tests in the clinical practice of any Pathology service.

The study, published in Medicine & Science in Sports & Exercise, identifies a causal relationship between a greater genetic predisposition for adequate cardiorespiratory capacity and a lower risk of developing these conditions.

The results suggest that increasing aerobic activity may provide protection against various cardiovascular, inflammatory, and other diseases.

The findings, published in Nature Communications, open the door to new prognostic markers and potential therapeutic strategies.

Targeting tumor cell adhesion impairs their ability to migrate and form metastases. The study was conducted using a preclinical mouse model.

However, it also finds that, in the experiences evaluated, the measure may increase the unequal distribution of roles between women and men. It notes that women devote more time to caregiving and domestic work, while men spend more on leisure.

The researchers conducted a systematic review of the scientific evidence surrounding this type of measure. They highlight that any initiative in this field must also include an analysis of other working conditions that may have an impact on health.

The most frequent cancers in Europe are breast, prostate, colorectal, and lung cancer. The highest survival rates a re seen in breast and prostate cancer, while pancreatic cancer has the poorest prognosis.

Databases from Spain, Estonia, and Switzerland show the best survival rates.

The study analysed brain MRI scans from nearly 100 individuals-patients with first-episode psychosis and healthy volunteers-using a novel technique that measures extracellular free water. This is the first study to apply this method to examine the effects of cannabis use in psychosis.

The findings are published in Molecular Psychiatry and reinforce recommendations against cannabis use in people with psychotic disorders.

Overall, 28-day mortality after suffering a heart attack decreased significantly, falling from 27% of cases to 19%.

These findings are highlighted in a study by researchers from the Hospital del Mar Research Institute, in collaboration with Hospital de Sant Pau and Hospital Clínic de Barcelona, which analysed data from 100,000 people who suffered a heart attack in Catalonia between 2008 and 2019.

The study, published in Science Advances, shows that eliminating these cells at an early stage of tumor growth promotes tumor proliferation and the formation of metastases.

By contrast, combining their elimination with an inhibitor of the CCL2 molecule reduces tumor size and eliminates metastases.

The new company, a spin-off of the Hospital del Mar Research Institute Barcelona, plans to launch its first human clinical trial in 2028 to validate the safety of this approach.

The project is led by Drs. Toni Celià-Terrassa and Joan Albanell, pioneers in the development of nanotherapies designed to transform tumours that are resistant to immunotherapy into tumours that are vulnerable to treatment.